{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T15:14:10Z","timestamp":1778512450627,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"8-9","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007343","name":"Shire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007343","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Cardiovascular Diseases"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.acvd.2020.04.008","type":"journal-article","created":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T22:22:58Z","timestamp":1596666178000},"page":"542-550","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["The value of electrocardiography and echocardiography in distinguishing Fabry\u00a0disease from sarcomeric hypertrophic cardiomyopathy"],"prefix":"10.1016","volume":"113","author":[{"given":"Nicolas","family":"Junqua","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damien","family":"Legallois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Segard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Lairez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"R\u00e9ant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyril","family":"Goizet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9l\u00e8ne","family":"Maillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Charron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Milliez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabien","family":"Labombarda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.acvd.2020.04.008_bib0210","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(08)61589-5","article-title":"Fabry's disease","volume":"372","author":"Zarate","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.acvd.2020.04.008_bib0215","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-138-4-200302180-00014","article-title":"Fabry disease, an under-recognised multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy","volume":"138","author":"Desnick","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.acvd.2020.04.008_bib0220","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.acvd.2020.04.008_bib0225","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1093\/eurheartj\/ehs166","article-title":"Left ventricular hypertrophy in Fabry disease: a practical approach to diagnosis","volume":"34","author":"Yousef","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2020.04.008_bib0230","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/jmg.2008.065904","article-title":"Natural course of Fabry disease: changing pattern of causes of death in FOS \u2013 Fabry Outcome Survey","volume":"46","author":"Mehta","year":"2009","journal-title":"J Med Genet"},{"key":"10.1016\/j.acvd.2020.04.008_bib0235","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/GIM.0b013e3181bb05bb","article-title":"Life expectancy and cause of death in males and females with Fabry disease: findings from the Fabry Registry","volume":"11","author":"Waldek","year":"2009","journal-title":"Genet Med"},{"key":"10.1016\/j.acvd.2020.04.008_bib0240","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2020.04.008_bib0245","doi-asserted-by":"crossref","first-page":"e000567","DOI":"10.1136\/openhrt-2016-000567","article-title":"Enhancing the diagnosis of Fabry disease in cardiology with a targeted information: a before\u2013after control-impact study","volume":"4","author":"Savary","year":"2017","journal-title":"Open Heart"},{"key":"10.1016\/j.acvd.2020.04.008_bib0250","first-page":"71","article-title":"Time delays in the diagnosis and treatment of Fabry disease","author":"Reisin","year":"2017","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.acvd.2020.04.008_bib0255","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s10545-007-0521-2","article-title":"Fabry disease: baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry","volume":"30","author":"Eng","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.acvd.2020.04.008_bib0260","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2362.2004.01309.x","article-title":"Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey","volume":"34","author":"Mehta","year":"2004","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.acvd.2020.04.008_bib0265","first-page":"100454","article-title":"The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: a systematic literature review by a European panel of experts","volume":"19","author":"Germain","year":"2019","journal-title":"Mol Genet Metab Rep"},{"key":"10.1016\/j.acvd.2020.04.008_bib0270","first-page":"1313","article-title":"Multimodality imaging in Fabry cardiomyopathy: from early diagnosis to therapeutic targets","volume":"19","author":"Militaru","year":"2018","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.acvd.2020.04.008_bib0275","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/eurheartj\/ehs397","article-title":"Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases","volume":"34","author":"Rapezzi","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2020.04.008_bib0280","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.amjcard.2011.09.052","article-title":"Value of electrocardiogram in the differentiation of hypertensive heart disease, hypertrophic cardiomyopathy, aortic stenosis, amyloidosis, and Fabry disease","volume":"109","author":"Namdar","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.acvd.2020.04.008_bib0285","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.jacc.2008.12.015","volume":"53","author":"Hancock","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2020.04.008_bib0290","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.acvd.2020.04.008_bib0295","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/CIRCIMAGING.112.000070","article-title":"Identification and assessment of Anderson\u2013Fabry disease by cardiovascular magnetic resonance non-contrast myocardial T1 mapping","volume":"6","author":"Sado","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.acvd.2020.04.008_bib0300","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/echo.13496","article-title":"Loss of base-to-apex circumferential strain gradient: a specific pattern of Fabry cardiomyopathy?","volume":"34","author":"Labombarda","year":"2017","journal-title":"Echocardiography"},{"key":"10.1016\/j.acvd.2020.04.008_bib0305","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/ejechocard\/jer112","article-title":"The endocardial binary appearance (\u201cbinary sign\u201d) is an unreliable marker for echocardiographic detection of Fabry disease in patients with left ventricular hypertrophy","volume":"12","author":"Mundigler","year":"2011","journal-title":"Eur J Echocardiogr"},{"key":"10.1016\/j.acvd.2020.04.008_bib0310","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ultrasmedbio.2010.10.017","article-title":"Prominent papillary muscles in Fabry disease: a diagnostic marker?","volume":"37","author":"Niemann","year":"2011","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.acvd.2020.04.008_bib0315","first-page":"883","article-title":"Clinical features, diagnosis, and management of patients with Anderson\u2013Fabry cardiomyopathy","volume":"33","author":"Yogasundaram","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.acvd.2020.04.008_bib0320","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fcvm.2016.00007","article-title":"Electrocardiographic changes and arrhythmia in Fabry disease","volume":"3","author":"Namdar","year":"2016","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.acvd.2020.04.008_bib0325","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1136\/heart.89.8.882","article-title":"QT dispersion and left ventricular morphology in patients with hypertrophic cardiomyopathy","volume":"89","author":"Sakata","year":"2003","journal-title":"Heart"},{"key":"10.1016\/j.acvd.2020.04.008_bib0330","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMoa033349","article-title":"Glycogen storage diseases presenting as hypertrophic cardiomyopathy","volume":"352","author":"Arad","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2020.04.008_bib0335","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.amjcard.2009.10.056","article-title":"PQ interval in patients with Fabry disease","volume":"105","author":"Namdar","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.acvd.2020.04.008_bib0340","first-page":"19","article-title":"Electrical changes in resting, exercise, and Holter electrocardiography in Fabry cardiomyopathy","volume":"28","author":"Kramer","year":"2016","journal-title":"JIMD Rep"},{"key":"10.1016\/j.acvd.2020.04.008_bib0345","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jjcc.2007.12.001","article-title":"Terminal stage cardiac findings in patients with cardiac Fabry disease: an electrocardiographic, echocardiographic, and autopsy study","volume":"51","author":"Takenaka","year":"2008","journal-title":"J Cardiol"},{"key":"10.1016\/j.acvd.2020.04.008_bib0350","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1651-2227.2002.tb03105.x","article-title":"Electrocardiographic signs of hypertrophy in Fabry disease-associated hypertrophic cardiomyopathy","volume":"91","author":"Kampmann","year":"2002","journal-title":"Acta Paediatr Suppl"},{"key":"10.1016\/j.acvd.2020.04.008_bib0355","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1161\/CIRCEP.114.002569","article-title":"Pathology and function of conduction tissue in Fabry disease cardiomyopathy","volume":"8","author":"Frustaci","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.acvd.2020.04.008_bib0360","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s10545-012-9540-8","article-title":"Cross-sectional baseline analysis of electrocardiography in a large cohort of patients with untreated Fabry disease","volume":"36","author":"Niemann","year":"2013","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.acvd.2020.04.008_bib0365","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0002-8703(77)80064-1","article-title":"Electrocardiographic and vectorcardiographic abnormalities in Fabry's disease","volume":"93","author":"Mehta","year":"1977","journal-title":"Am Heart J"},{"key":"10.1016\/j.acvd.2020.04.008_bib0370","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ijcard.2005.08.023","article-title":"Simple criteria for differentiation of Fabry disease from amyloid heart disease and other causes of left ventricular hypertrophy","volume":"111","author":"Hoigne","year":"2006","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.acvd.2020.04.008_bib0375","first-page":"47","article-title":"Electrocardiogram performance in the diagnosis of left ventricular hypertrophy in hypertensive patients with left bundle branch block","volume":"108","author":"Burgos","year":"2017","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.acvd.2020.04.008_bib0380","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0735-1097(94)00371-V","article-title":"Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products","volume":"25","author":"Okin","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2020.04.008_bib0385","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3109\/13506129.2015.1037831","article-title":"Can echocardiography and ECG discriminate hereditary transthyretin V30M amyloidosis from hypertrophic cardiomyopathy?","volume":"22","author":"Gustavsson","year":"2015","journal-title":"Amyloid"},{"key":"10.1016\/j.acvd.2020.04.008_bib0390","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/eurheartj\/ehp426","article-title":"Aortic remodelling in Fabry disease","volume":"31","author":"Barbey","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2020.04.008_bib0395","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1651-2227.2003.tb00222.x","article-title":"Sequelae of storage in Fabry disease \u2013 pathology and comparison with other lysosomal storage diseases","volume":"92","author":"Elleder","year":"2003","journal-title":"Acta Paediatr Suppl"},{"key":"10.1016\/j.acvd.2020.04.008_bib0400","doi-asserted-by":"crossref","first-page":"w14517","DOI":"10.4414\/smw.2017.14517","article-title":"Ascending aortic remodelling in Fabry disease after long-term enzyme replacement therapy","volume":"147","author":"Monney","year":"2017","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.acvd.2020.04.008_bib0405","doi-asserted-by":"crossref","first-page":"55","DOI":"10.7326\/M14-0697","article-title":"Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement","volume":"162","author":"Collins","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.acvd.2020.04.008_bib0410","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1161\/CIRCULATIONAHA.108.794529","article-title":"Long-term effects of enzyme replacement therapy on Fabry cardiomyopathy: evidence for a better outcome with early treatment","volume":"119","author":"Weidemann","year":"2009","journal-title":"Circulation"}],"container-title":["Archives of Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187521362030156X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187521362030156X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:46:18Z","timestamp":1761745578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187521362030156X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":41,"journal-issue":{"issue":"8-9","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S187521362030156X"],"URL":"https:\/\/doi.org\/10.1016\/j.acvd.2020.04.008","relation":{},"ISSN":["1875-2136"],"issn-type":[{"value":"1875-2136","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The value of electrocardiography and echocardiography in distinguishing Fabry\u00a0disease from sarcomeric hypertrophic cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Archives of Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acvd.2020.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}